Expert review of cardiovascular therapy

Keyphrases

Publications

volume 22, number 1-3, 2024

Cayla Pichan, Adam D DeVore
Rural and urban hospitals in the United States: does location affect care and outcomes of patients with heart failure? Expert review of cardiovascular therapy 22 (1-3) (2024)
Cayla Pichan, Adam D DeVore
Rural and urban hospitals in the United States: does location affect care and outcomes of patients with heart failure? Expert review of cardiovascular therapy 22 (1-3) (2024)
Anthony S Wierzbicki
Preventive cardiology for the aging population: how can we better design clinical trials of statins? Expert review of cardiovascular therapy 22 (1-3) (2024)
Setor Kwadzo Kunutsor, Jari A Laukkanen
Physical activity, exercise and adverse cardiovascular outcomes in individuals with pre-existing cardiovascular disease: a narrative review. Expert review of cardiovascular therapy 22 (1-3) (2024)
Prashant D Bhave, Elsayed Soliman
Should patients with diabetes be routinely screened for atrial fibrillation? Expert review of cardiovascular therapy 22 (1-3) (2024)
Xavier García-Moll, Francesco Croci, Alexandra Solé, Elisabeth S Hartgers-Gubbels, Miguel A Calleja-Hernández
A cost-effectiveness analysis of empagliflozin for heart failure patients across the full spectrum of ejection fraction in Spain: combined results of the EMPEROR-Preserved and EMPEROR-Reduced trials. Expert review of cardiovascular therapy 22 (1-3) (2024)
Simran Singh Parmar, Mohamed O Mohamed, Mamas Andreas Mamas, Ross Wilkie
The clinical characteristics, managements, and outcomes of acute myocardial infarction in osteoarthritis patients; a cross-sectional analysis of 6.5 million patients. Expert review of cardiovascular therapy 22 (1-3) (2024)
Eloi Vacher, Jean Baptiste Gourraud, Vincent Probst
When to ablate in Brugada and early repolarization syndromes. Expert review of cardiovascular therapy 22 (1-3) (2024)
Frederick Berro Rivera, Faye Salva, Jacques Simon Gonzales, Sung Whoy Cha, Samantha Tang, Grace Nooriza Opay Lumbang, Gurleen Kaur, Isabel Planek, Kyla Lara-Breitinger, Mark Dela Cruz, Tisha Marie B Suboc, Fareed Moses S Collado, Jonathan R Enriquez, Nishant Shah, Annabelle Santos Volgman
Sex differences in trends and outcomes of acute myocardial infarction with mechanical complications in the United States. Expert review of cardiovascular therapy 22 (1-3) (2024)
Kiera Liblik, Ioana Tereza Florica, Adrian Baranchuk
Original algorithms for the detection of cardiovascular involvement of neglected tropical diseases. Expert review of cardiovascular therapy 22 (1-3) (2024)
Simran Singh Parmar, Mohamed O Mohamed, Mamas Andreas Mamas, Ross Wilkie
The clinical characteristics, managements, and outcomes of acute myocardial infarction in osteoarthritis patients; a cross-sectional analysis of 6.5 million patients. Expert review of cardiovascular therapy 22 (1-3) (2024)
Seyed Younes Hosseini, Rahul Mallick, Petri Mäkinen, Suo Ctc Bladder Committee
Navigating the prime editing strategy to treat cardiovascular genetic disorders in transforming heart health. Expert review of cardiovascular therapy 22 (1-3) (2024)

volume 22, number 4-5, 2024

Richard J Jabbour, Nick Curzen
How will coronary physiology, plaque vulnerability and ischemia be integrated in future patient pathways with chest pain? Expert review of cardiovascular therapy 22 (4-5) (2024)
Kosmas I Paraskevas, Alan Dardik, Marc L Schermerhorn, Christos D Liapis, Armando Mansilha, Brajesh K Lal, William A Gray, Martin M Brown, Piotr Myrcha, Carl J Lavie, Clark J Zeebregts, Eric A Secemsky, Luca Saba, Matthew Blecha, Victor Gurevich, Mauro Silvestrini, Ales Blinc, Alexei Svetlikov, Jose Fernandes E Fernandes, Peter A Schneider, Peter Gloviczki, Christopher J White, Ali F AbuRahma
Why selective screening for asymptomatic carotid stenosis is currently appropriate: a special report. Expert review of cardiovascular therapy 22 (4-5) (2024)
Ricardo Polman, John R Hurst, Omer Faruk Uysal, Swapna Mandal, Dominik Linz, Sami Simons
Cardiovascular disease and risk in COPD: a state of the art review. Expert review of cardiovascular therapy 22 (4-5) (2024)
Marcos García-Guimarães, Teresa Bastante, David Del Val, Diego Fernández-Rodríguez, Teresa Guiberteau-Diaz, Jorge Salamanca, Fernando Rivero, Fernando Alfonso
Angiographic patterns in spontaneous coronary artery dissection: novel diagnostic insights. Expert review of cardiovascular therapy 22 (4-5) (2024)
Ricardo Polman, John R Hurst, Omer Faruk Uysal, Swapna Mandal, Dominik Linz, Sami Simons
Cardiovascular disease and risk in COPD: a state of the art review. Expert review of cardiovascular therapy 22 (4-5) (2024)
Marie-A Chaix, Réda Ibrahim, Jean-Claude Tardif, Colombe Roy, François-Pierre Mongeon, Annie Dore, Blandine Mondésert, Paul Khairy
Pulmonary vascular disease and optical coherence tomography imaging in patients with Fontan palliation. Expert review of cardiovascular therapy 22 (4-5) (2024)
Yangfeng Wu, Yifang Yuan
The best of 'best buys': public health values of potassium-enriched salt substitute. Expert review of cardiovascular therapy 22 (4-5) (2024)
Kosmas I Paraskevas, Alan Dardik, Marc L Schermerhorn, Christos D Liapis, Armando Mansilha, Brajesh K Lal, William A Gray, Martin M Brown, Piotr Myrcha, Carl J Lavie, Clark J Zeebregts, Eric A Secemsky, Luca Saba, Matthew Blecha, Victor Gurevich, Mauro Silvestrini, Ales Blinc, Alexei Svetlikov, Jose Fernandes E Fernandes, Peter A Schneider, Peter Gloviczki, Christopher J White, Ali F AbuRahma
Why selective screening for asymptomatic carotid stenosis is currently appropriate: a special report. Expert review of cardiovascular therapy 22 (4-5) (2024)
Kosmas I Paraskevas, Alan Dardik, Marc L Schermerhorn, Christos D Liapis, Armando Mansilha, Brajesh K Lal, William A Gray, Martin M Brown, Piotr Myrcha, Carl J Lavie, Clark J Zeebregts, Eric A Secemsky, Luca Saba, Matthew Blecha, Victor Gurevich, Mauro Silvestrini, Ales Blinc, Alexei Svetlikov, Jose Fernandes E Fernandes, Peter A Schneider, Peter Gloviczki, Christopher J White, Ali F AbuRahma
Why selective screening for asymptomatic carotid stenosis is currently appropriate: a special report. Expert review of cardiovascular therapy 22 (4-5) (2024)
Marcos García-Guimarães, Teresa Bastante, David Del Val, Diego Fernández-Rodríguez, Teresa Guiberteau-Diaz, Jorge Salamanca, Fernando Rivero, Fernando Alfonso
Angiographic patterns in spontaneous coronary artery dissection: novel diagnostic insights. Expert review of cardiovascular therapy 22 (4-5) (2024)
Frederick Berro Rivera, Sung Whoy Cha, Mara Bernadette Liston, Sonny Redula, Nathan Ross B Bantayan, Nishant Shah, Mamas A Mamas, Annabelle Santos Volgman
Sex differences in trends and in-hospital outcomes of acute myocardial infarction in patients with familial hypercholesterolemia: insights from a large national database. Expert review of cardiovascular therapy 22 (4-5) (2024)
Tom Wong
Aveir VR leadless pacemaker: interview with professor Tom Wong. Expert review of cardiovascular therapy 22 (4-5) (2024)
Marie-A Chaix, Réda Ibrahim, Jean-Claude Tardif, Colombe Roy, François-Pierre Mongeon, Annie Dore, Blandine Mondésert, Paul Khairy
Pulmonary vascular disease and optical coherence tomography imaging in patients with Fontan palliation. Expert review of cardiovascular therapy 22 (4-5) (2024)

volume 22, number 6, 2024

Amanda R Bonikowske, Jenna L Taylor, Kathryn F Larson, Joel Hardwick, Cemal Ozemek, Matthew P Harber, Lenny A Kaminsky, Ross Arena, Carl J Lavie
Evaluating current assessment techniques of cardiorespiratory fitness. Expert review of cardiovascular therapy 22 (6) (2024)
Ryosuke Sato, Stephan von Haehling
Targeting obesity for therapeutic intervention in heart failure patients. Expert review of cardiovascular therapy 22 (6) (2024)
Elizabeth G Dieter, Aravinda Nanjundappa
Sex differences in acute myocardial infarction. Expert review of cardiovascular therapy 22 (6) (2024)
Steven G Chrysant
The role of gut microbiota in the development of salt-sensitive hypertension and the possible preventive effect of exercise. Expert review of cardiovascular therapy 22 (6) (2024)
Paul Jie Wen Tern, Khung Keong Yeo, Jack Wei Chieh Tan, Chee Tang Chin, Ru San Tan, Jonathan Yap
Role of anticoagulation in non-ST-elevation myocardial infarction: a contemporary narrative review. Expert review of cardiovascular therapy 22 (6) (2024)
Antonis A Manolis, Theodora A Manolis, Antonis S Manolis
Managing chronic coronary syndrome: how do we achieve optimal patient outcomes? Expert review of cardiovascular therapy 22 (6) (2024)
Taehwan Park, Monica Hwang
Safety of cardiovascular disease drugs approved between 2014 and 2021 in the US: a pharmacovigilance analysis. Expert review of cardiovascular therapy 22 (6) (2024)

volume 22, number 7, 2024

John Stone, Manish Kumar, Ariela R Orkaby
The role of statin therapy in older adults: best practices and unmet challenges. Expert review of cardiovascular therapy 22 (7) (2024)
John Stone, Manish Kumar, Ariela R Orkaby
The role of statin therapy in older adults: best practices and unmet challenges. Expert review of cardiovascular therapy 22 (7) (2024)
Lin-Thiri Toon, John Paisey, Paul R Roberts
The dual chamber leadless pacemaker: a game changer for bradycardia management? Expert review of cardiovascular therapy 22 (7) (2024)
John Stone, Manish Kumar, Ariela R Orkaby
The role of statin therapy in older adults: best practices and unmet challenges. Expert review of cardiovascular therapy 22 (7) (2024)
Lin-Thiri Toon, John Paisey, Paul R Roberts
The dual chamber leadless pacemaker: a game changer for bradycardia management? Expert review of cardiovascular therapy 22 (7) (2024)
Mark A Sammut, Dwayne Conway, Javaid Iqbal, Arvindra Krishnamurthy, Kenneth P Morgan, Paul D Morris, James D Richardson, Alexander M K Rothman, Julian P Gunn, Robert F Storey
Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation. Expert review of cardiovascular therapy 22 (7) (2024)
John Stone, Manish Kumar, Ariela R Orkaby
The role of statin therapy in older adults: best practices and unmet challenges. Expert review of cardiovascular therapy 22 (7) (2024)
Bjørn Strøier Larsen, Tor Biering-Sørensen, Flemming Javier Olsen
Ischemic stroke and the emerging role of left atrial function. Expert review of cardiovascular therapy 22 (7) (2024)
Carolina Montonati, Dario Pellegrini, Daniele Oreste d'Atri, Mariano Pellicano, Daniele Briguglia, Francesco Giannini, Giuseppe De Blasio, Giulio Guagliumi, Maurizio Tespili, Alfonso Ielasi
A novel balloon-expandable transcatheter aortic valve bioprosthesis: Myval and Myval Octacor. Expert review of cardiovascular therapy 22 (7) (2024)
Carolina Montonati, Dario Pellegrini, Daniele Oreste d'Atri, Mariano Pellicano, Daniele Briguglia, Francesco Giannini, Giuseppe De Blasio, Giulio Guagliumi, Maurizio Tespili, Alfonso Ielasi
A novel balloon-expandable transcatheter aortic valve bioprosthesis: Myval and Myval Octacor. Expert review of cardiovascular therapy 22 (7) (2024)
Taylor R Anderson, Kasim Qureshi, Muhammad U Farooq, Philip B Gorelick
Population-based approaches for reducing stroke risk: an update on their success and the challenges ahead. Expert review of cardiovascular therapy 22 (7) (2024)
Bjørn Strøier Larsen, Tor Biering-Sørensen, Flemming Javier Olsen
Ischemic stroke and the emerging role of left atrial function. Expert review of cardiovascular therapy 22 (7) (2024)
Carolina Montonati, Dario Pellegrini, Daniele Oreste d'Atri, Mariano Pellicano, Daniele Briguglia, Francesco Giannini, Giuseppe De Blasio, Giulio Guagliumi, Maurizio Tespili, Alfonso Ielasi
A novel balloon-expandable transcatheter aortic valve bioprosthesis: Myval and Myval Octacor. Expert review of cardiovascular therapy 22 (7) (2024)
Mark A Sammut, Dwayne Conway, Javaid Iqbal, Arvindra Krishnamurthy, Kenneth P Morgan, Paul D Morris, James D Richardson, Alexander M K Rothman, Julian P Gunn, Robert F Storey
Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation. Expert review of cardiovascular therapy 22 (7) (2024)
Mark A Sammut, Dwayne Conway, Javaid Iqbal, Arvindra Krishnamurthy, Kenneth P Morgan, Paul D Morris, James D Richardson, Alexander M K Rothman, Julian P Gunn, Robert F Storey
Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation. Expert review of cardiovascular therapy 22 (7) (2024)
Mark A Sammut, Dwayne Conway, Javaid Iqbal, Arvindra Krishnamurthy, Kenneth P Morgan, Paul D Morris, James D Richardson, Alexander M K Rothman, Julian P Gunn, Robert F Storey
Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation. Expert review of cardiovascular therapy 22 (7) (2024)
Mark A Sammut, Dwayne Conway, Javaid Iqbal, Arvindra Krishnamurthy, Kenneth P Morgan, Paul D Morris, James D Richardson, Alexander M K Rothman, Julian P Gunn, Robert F Storey
Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation. Expert review of cardiovascular therapy 22 (7) (2024)
Taylor R Anderson, Kasim Qureshi, Muhammad U Farooq, Philip B Gorelick
Population-based approaches for reducing stroke risk: an update on their success and the challenges ahead. Expert review of cardiovascular therapy 22 (7) (2024)